Technology News and Research

RSS

Improving tuberculosis (TB) diagnosis: an interview with Professor Madhukar Pai, MD, PhD

TB is an infectious disease caused by Mycobacterium tuberculosis. Nearly 9 million people develop TB every year, and TB kills nearly 1.4 million individuals each year. While the incidence of TB has steadily declined in the west, it remains a huge public health problem in many developing countries, with India having the highest burden.

15 Feb 2013

Researchers show how gene mutations shift and evolve over time in chronic lymphocytic leukemia

Tumors are not factories for the mass production of identical cancer cells, but are, in reality, patchworks of cells with different patterns of gene mutations. In a new study, researchers at Dana-Farber Cancer Institute and the Broad Institute show, more fully than ever before, how these mutations shift and evolve over time in chronic lymphocytic leukemia (CLL) - providing a strobe-like look at the genetic past, present, and future of CLL tumors.

15 Feb 2013

Pivotal Response Treatment improves brain activity in children with autism

Using functional magnetic resonance imaging (fMRI) for before-and-after analysis, a team of researchers including a UC Santa Barbara graduate student discovered positive changes in brain activity in children with autism who received a particular type of behavioral therapy.

15 Feb 2013

Marshfield Clinic’s Heart Health Mobile app wins HSS competition

Marshfield Clinic Research Foundation, a division of Marshfield Clinic, announced today that its first completed mobile app has won a national competition that challenged competitors to develop a program that will help improve heart health in the U.S.

15 Feb 2013

Gamida Cell announces results from NiCord Phase I/II study on hematological malignancies

Gamida Cell announced today the successful results of the Phase I/II study of its second pipeline product NiCord, umbilical cord derived stem cells expanded using the company's proprietary NAM technology.

15 Feb 2013

Roundup: States get insurance exchange weapon on abortion; N.Y. budget woes include Medicaid money worry; Ga. hospital 'bed tax' might not offer budget solution

Abortion opponents have found a new way to restrict access to abortion -- by using the authority states have over the new health insurance exchanges, which will be up and running in a year. At least 21 states have legislation in place or in the works that will stop health insurance companies from paying for abortions for women.

15 Feb 2013

SQI Diagnostics reports net loss of $1,563,000 for quarter-ended December 31, 2012

SQI Diagnostics Inc., a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced its financial and operational results for the first quarter-ended December 31, 2012.

15 Feb 2013

Health care staff can use QPID's intelligence engine to gain better insights from EHRs

QPID Inc. launched today, delivering a new health record intelligence platform and web-based applications that enable health care institutions and clinicians to gain better insights from any Electronic Health Record (EHR).

15 Feb 2013

Personalis announces availability of Genome Services for Research

Personalis, Inc. today announced availability of its Genome Services for Research, focusing on accuracy in sequencing, analysis, and interpretation of human genomes. Personalis believes that accuracy is crucial in medicine, both in research and ultimately in clinical use.

14 Feb 2013

Santarus launches UCERIS for induction of remission in patients with ulcerative colitis

Santarus, Inc. announced today the U.S. commercial launch of UCERIS (budesonide) extended release tablets for the induction of remission in patients with active, mild to moderate ulcerative colitis.

14 Feb 2013

Amblyopia screening guidelines updated

The American Association for Pediatric Ophthalmology and Strabismus, the professional body for pediatric eye care, has issued revised guidelines for preschool vision screening based on new evidence.

14 Feb 2013

L-COR Biosciences launches C-DiGit Blot Scanner

Today, LI-COR Biosciences continues to demonstrate its position as a leader in laboratory instrument systems as it announces the launch of the C-DiGit Blot Scanner.

14 Feb 2013

Regeneron fourth quarter total revenues increase to $415 million

Regeneron Pharmaceuticals, Inc. today announced financial and operating results for the fourth quarter and full year 2012 and provided an update on development programs.

14 Feb 2013

Canada-US-Italian research team develops nature-inspired cocaine biosensor

Since the beginning of time, living organisms have developed ingenious mechanisms to monitor their environment. As part of an international study, a team of researchers has adapted some of these natural mechanisms to detect specific molecules such as cocaine more accurately and quickly. Their work may greatly facilitate the rapid screening-less than five minutes-of many drugs, infectious diseases, and cancers.

14 Feb 2013

Fluke Biomedical receives FDA clearance for ESA615 Electrical Safety Analyzer

The United States Food and Drug Administration (FDA) announced today it has granted the new automated, multifunctional ESA615 Electrical Safety Analyzer 510(k) clearance.

14 Feb 2013

FDA grants IDE approval to STS and ACC to study alternative access approaches for TAVR

The Society of Thoracic Surgeons (STS) and the American College of Cardiology (ACC) have received a unique investigational device exemption (IDE) from the U.S. Food and Drug Administration (FDA) to study "alternative access" approaches for transcatheter aortic valve replacement (TAVR) using the STS/ACC TVT Registry.

14 Feb 2013

Medgenics closes public offering of 5,600,000 shares of common stock and warrants

Medgenics, Inc., the developer of a novel platform technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, announces yesterday's closing of an underwritten public offering of 5,600,000 shares of common stock and Series 2013-A warrants to purchase up to an aggregate of 2,800,000 shares of common stock.

14 Feb 2013

FOXC2 vital to epithelial-mesenchymal transition in breast cancer

Researchers have identified a pivotal protein in a cellular transformation that makes a cancer cell more resistant to treatment and more capable of growing and spreading, making it an inviting new target for drug development.

14 Feb 2013

Link between Jagged-1 protein and bone formation

Researchers from the University of Pennsylvania School of Veterinary Medicine have discovered that a protein called Jagged-1 stimulates human stem cells to differentiate into bone-producing cells.

14 Feb 2013

FDA grants orphan drug status to Lentigen’s LG631-CD34 for treatment of glioblastoma multiforme

Lentigen Corporation, a biotechnology company specializing in the development and manufacture of lentiviral gene delivery products, announced today that that the U.S. Food and Drug Administration (FDA) has granted orphan drug status to P140K methylguanine methyltransferase (MGMT) transduced human CD34 cells for bone marrow protection in the treatment of glioblastoma multiforme.

14 Feb 2013

Technology News and Research

Improving tuberculosis (TB) diagnosis: an interview with Professor Madhukar Pai, MD, PhD

Researchers show how gene mutations shift and evolve over time in chronic lymphocytic leukemia

Pivotal Response Treatment improves brain activity in children with autism

Marshfield Clinic’s Heart Health Mobile app wins HSS competition

Gamida Cell announces results from NiCord Phase I/II study on hematological malignancies

Roundup: States get insurance exchange weapon on abortion; N.Y. budget woes include Medicaid money worry; Ga. hospital 'bed tax' might not offer budget solution

SQI Diagnostics reports net loss of $1,563,000 for quarter-ended December 31, 2012

Health care staff can use QPID's intelligence engine to gain better insights from EHRs

Personalis announces availability of Genome Services for Research

Santarus launches UCERIS for induction of remission in patients with ulcerative colitis

Amblyopia screening guidelines updated

L-COR Biosciences launches C-DiGit Blot Scanner

Regeneron fourth quarter total revenues increase to $415 million

Canada-US-Italian research team develops nature-inspired cocaine biosensor

Fluke Biomedical receives FDA clearance for ESA615 Electrical Safety Analyzer

FDA grants IDE approval to STS and ACC to study alternative access approaches for TAVR

Medgenics closes public offering of 5,600,000 shares of common stock and warrants

FOXC2 vital to epithelial-mesenchymal transition in breast cancer

Link between Jagged-1 protein and bone formation

FDA grants orphan drug status to Lentigen’s LG631-CD34 for treatment of glioblastoma multiforme

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News